Gene · 9201
Papers1,726
Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.
201 to 220 of 1,726
Download this page as JSON| Title | Journal | Year | PMID | Found by | Source |
|---|---|---|---|---|---|
| Advances in tuft cells, a chemosensory cell in sequential diseases of the pancreas. | Biochim Biophys Acta Rev Cancer | 2023 | 37182665 | PubTator, text mining | PubMed |
| Roles of cancer stem cells in gastrointestinal cancers. | World J Stem Cells | 2023 | 37181004 | PubTator, text mining | PubMed |
| Cell Therapy as Target Therapy against Colon Cancer Stem Cells. | Int J Mol Sci | 2023 | 37175871 | PubTator, text mining | PubMed |
| UVRAG Promotes Tumor Progression through Regulating SP1 in Colorectal Cancer. | Cancers (Basel) | 2023 | 37173968 | PubTator, text mining | PubMed |
| Downregulation of microRNA‑494 inhibits cell proliferation in lung squamous cell carcinoma via the induction of PUMA‑α‑mediated apoptosis. | Exp Ther Med | 2023 | 37153893 | PubTator, text mining | PubMed |
| Long noncoding RNA 01534 maintains cancer stemness by downregulating endoplasmic reticulum stress response in colorectal cancer. | Ann Gastroenterol Surg | 2023 | 37152770 | PubTator, text mining | PubMed |
| Organoid models of fibrolamellar carcinoma mutations reveal hepatocyte transdifferentiation through cooperative BAP1 and PRKAR2A loss. | Nat Commun | 2023 | 37137901 | PubTator, text mining | PubMed |
| Ecological niches for colorectal cancer stem cell survival and thrival. | Front Oncol | 2023 | 37124519 | PubTator, text mining | PubMed |
| Identifying Aging and Alzheimer Disease-Associated Somatic Variations in Excitatory Neurons From the Human Frontal Cortex. | Neurol Genet | 2023 | 37123987 | PubTator, text mining | PubMed |
| Natural Compounds Targeting the Autophagy Pathway in the Treatment of Colorectal Cancer. | Int J Mol Sci | 2023 | 37108476 | PubTator, text mining | PubMed |
| Alveolar-Capillary Barrier Protection In Vitro: Lung Cell Type-Specific Effects and Molecular Mechanisms Induced by 1α, 25-Dihydroxyvitamin D3. | Int J Mol Sci | 2023 | 37108455 | PubTator, text mining | PubMed |
| Cancer Stem Cells in Pancreatic Ductal Adenocarcinoma. | Int J Mol Sci | 2023 | 37108193 | PubTator, text mining | PubMed |
| Challenges of EGFR-TKIs in NSCLC and the potential role of herbs and active compounds: From mechanism to clinical practice. | Front Pharmacol | 2023 | 37089959 | PubTator, text mining | PubMed |
| Retraction notice to "miR-539 enhances chemosensitivity to cisplatin in non-small cell lung cancer by targeting DCLK1" [Biomed. Pharmacother. 106 (2018) 1072-1081]. | Biomed Pharmacother | 2023 | 37087344 | PubTator, text mining | PubMed |
| Targeting DCLK1 attenuates tumor stemness and evokes antitumor immunity in triple-negative breast cancer by inhibiting IL-6/STAT3 signaling. | Breast Cancer Res | 2023 | 37069669 | PubTator, text mining | PubMed |
| Comprehensive proteome, phosphoproteome and kinome characterization of luminal A breast cancer. | Front Oncol | 2023 | 37064116 | PubTator, text mining | PubMed |
| High expression of the RET receptor tyrosine kinase and its ligand GDNF identifies a high-risk subset of estrogen receptor positive breast cancer. | Breast Cancer Res Treat | 2023 | 37061618 | PubTator, text mining | PubMed |
| Integrating genome-wide association study with regulatory SNP annotations identified novel candidate genes for osteoporosis. | Bone Joint Res | 2023 | 37051837 | PubTator, text mining | PubMed |
| Primary Cilium Identifies a Quiescent Cell Population in the Human Intestinal Crypt. | Cells | 2023 | 37048132 | PubTator, text mining | PubMed |
| Cytokine Signatures in Psoriatic Arthritis Patients Indicate Different Phenotypic Traits Comparing Responders and Non-Responders of IL-17A and TNFα Inhibitors. | Int J Mol Sci | 2023 | 37047315 | PubTator, text mining | PubMed |
gene-search-2026-11-11-0.2.0
Sources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/genes/v1/9201/papers?page=11